* European Commission Approves The First And Only
Immuno-Oncology Combination, Bristol-Myers Squibb’s Opdivo
(Nivolumab) + Yervoy (Ipilimumab) Regimen, For Treatment Of
Advanced Melanoma
The post BRIEF-Bristol-Myers says EU advanced melanoma drug appeared first on NASDAQ.